← Back to Search

1 for Interstitial Cystitis

N/A
Waitlist Available
Led By Michael Chancellor, MD
Research Sponsored by William Beaumont Hospitals
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Summary

Completion of a brief survey tool and providing an urine specimen. The study purpose is to improve our understanding of interstitial cystitis and painful pelvic syndrome.

Eligible Conditions
  • Interstitial Cystitis
  • Pelvic Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

1Treatment groups
Experimental Treatment
Group I: 1Experimental Treatment1 Intervention
patients will be asked to provide a urine specimen and complete a questionnaire.

Find a Location

Who is running the clinical trial?

William Beaumont HospitalsLead Sponsor
151 Previous Clinical Trials
112,616 Total Patients Enrolled
10 Trials studying Interstitial Cystitis
4,233 Patients Enrolled for Interstitial Cystitis
Michael Chancellor, MDPrincipal InvestigatorWilliam Beaumont Hospitals
2 Previous Clinical Trials
45 Total Patients Enrolled
1 Trials studying Interstitial Cystitis
15 Patients Enrolled for Interstitial Cystitis
~2 spots leftby Oct 2025